Altered mRNA Expression of Interleukin-1 Receptors in Myocardial Tissue of Patients with Left Ventricular Assist Device Support
Authors:
- Naima NiazyNNNaima Niazy
- Linus MrozekLMLinus Mrozek
- Mareike BarthMareike Barth
- Moritz Benjamin ImmohrMoritz Benjamin Immohr
- Nikolaos KalampokasNKNikolaos Kalampokas
- Diyar SaeedDSDiyar Saeed
- Hug AubinHAHug Aubin
- Yukiharu SugimuraYukiharu Sugimura
- Ralf WestenfeldRWRalf Westenfeld
- Udo BoekenUBUdo Boeken
- Artur LichtenbergALArtur Lichtenberg
- Payam AkhyariPayam Akhyari
Open Access
- 22 October 2021
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (21) , 4856
Abstract
Serum levels of cytokines interleukin 1 beta ( IL-1β) and interleukin 33 (IL-33) are highly abnormal in heart failure and remain elevated after mechanical circulatory support (MCS). However, local cytokine signaling induction remains elusive. Left (LV) and right ventricular (RV) myocardial tissue specimens of end-stage heart failure (HF) patients without (n = 24) and with MCS (n = 39; 594 ± 57 days) were analyzed for cytokine mRNA expression level of IL-1B, interleukin 1 receptor 1/2 (IL-1R1/2), interleukin 1 receptor-like 1 (IL-1RL1), IL-33 and interleukin-1 receptor accessory protein (IL-1RaP). MCS patients showed significantly elevated IL-1B expression levels (LV: 2.0 fold, p = 0.0058; RV: 3.3 fold, p < 0.0001). Moreover, IL-1R1, IL-1RaP and IL-33 expression levels strongly correlated with each other. IL-1RL1 and IL-1R2 expression levels were significantly higher in RV myocardial tissue (RV/LV ratio IL-1R2 HF: 4.400 ± 1.359; MCS: 4.657 ± 0.655; IL-1RL1 HF: 3.697 ± 0.876; MCS: 4.529 ± 0.5839). In addition, IL1-RaP and IL-33 RV expression levels were significantly elevated in MCS. Furthermore, IL-33 expression correlates with C-reactive protein (CRP) plasma levels in HF, but not in MCS patients. Increased expression of IL-1B and altered correlation patterns of IL-1 receptors indicate enhanced IL-1β signaling in MCS patients. Correlation of IL-1 receptor expression with IL-33 may hint towards a link between both pathways. Moreover, diverging expression in LV and RV suggests specific regulation of local cytokine signaling.Keywords
This publication has 53 references indexed in Scilit:
- Heme Oxygenase-1 and Inflammation in Experimental Right Ventricular Failure on Prolonged Overcirculation-Induced Pulmonary HypertensionPLOS ONE, 2013
- Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculatureJournal of Molecular and Cellular Cardiology, 2013
- Alterations in the Interleukin-1/Interleukin-1 Receptor Antagonist Balance Modulate Cardiac Remodeling following Myocardial Infarction in the MousePLOS ONE, 2011
- Nonmyocardial Production of ST2 Protein in Human Hypertrophy and Failure Is Related to Diastolic LoadJACC, 2008
- Myocardial Fas and Cytokine Expression in End‐Stage Heart Failure: Impact of LVAD SupportClinical and Translational Science, 2008
- Nuclear Interleukin-33 Is Generally Expressed in Resting Endothelium but Rapidly Lost upon Angiogenic or Proinflammatory ActivationThe American Journal of Pathology, 2008
- Interleukin-1 Receptor Type I Signaling Critically Regulates Infarct Healing and Cardiac RemodelingThe American Journal of Pathology, 2008
- Pulmonary embolism causes endomyocarditis in the human heartHeart, 2007
- IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling systemJournal of Clinical Investigation, 2007
- Interleukin-1 in Myocardium and Coronary Arteries of Patients with Dilated CardiomyopathyJournal of Molecular and Cellular Cardiology, 1998